Candida albicans viability after exposure to amphotericin B: Assessment using metabolic assays and colony forming units

Journal of Microbiological Methods

Volumn 72, Issue 3, 2008, Pages 268-274

  Khot, Prasanna D ^a   Suci, Peter A ^b   Tyler, Bonnie J ^a  

^a Department of Electrical and Computer Engineering   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

Author keywords

AlamarBlue; Antifungal susceptibility testing; Candida albicans; Kinetic metabolic assay; XTT

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CELL ASSAY; CELL COUNT; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; GROWTH CURVE; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CHROMOGENIC COMPOUNDS; MICROBIAL VIABILITY; OXAZINES; STEM CELLS; TETRAZOLIUM SALTS; XANTHENES;

CANDIDA ALBICANS;

EID: 40049087571     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2007.12.005     Document Type: Article

References (42)

1. Antachopoulos C., Meletiadis J., Roilides E., Sein T., and Walsh T.J. Rapid susceptibility testing of medically important zygomycetes by XTT assay. J. Clin. Microbiol. 442 (2006) 553-560
2. Baillie G.S., and Douglas L.J. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 310 (1999) 644-656
3. Chandra J., Mukherjee P.K., Leidich S.D., Faddoul F.F., Hoyer L.L., Douglas L.J., et al. Antifungal resistance of Candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 803 (2001) 903-908
4. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science. 2845418 (1999) 1318-1322
5. Cuenca-Estrella M., and Rodriguez-Tudela J.L. Present status of the detection of antifungal resistance: the perspective from both sides of the ocean. Clin. Microbiol. Infect. 7 Suppl 2 (2001) 46-53
6. Davey K.G., Szekely A., Johnson E.M., and Warnock D.W. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans. J. Antimicrob. Chemother. 424 (1998) 439-444
7. Espinel-Ingroff A. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B. J. Clin. Microbiol. 4410 (2006) 3616-3622
8. Espinel-Ingroff A., Pfaller M., Messer S.A., Knapp C.C., Killian S., Norris H.A., et al. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. J. Clin. Microbiol. 373 (1999) 591-595
9. Gale E.F. The release of potassium ions from Candida albicans in the presence of polyene antibiotics. J. Gen. Microbiol. 802 (1974) 451-465
10. Gale E.F. Nature and development of phenotypic resistance to Amphotericin-B in Candida albicans. Adv. Microb. Physiol. 27 (1986) 277-320
11. Gonzalez R.J., and Tarloff J.B. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol. In Vitro. 153 (2001) 257-259
12. Han Y.M., Morrison R.P., and Cutler J.E. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. 6612 (1998) 5771-5776
13. Hawser S. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells. J. Med. Vet. Mycol. 342 (1996) 149-152
14. Hawser S.P., Norris H., Jessup C.J., and Ghannoum M.A. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol. 365 (1998) 1450-1452
15. Hospenthal D.R., Murray C.K., and Rinaldi M.G. The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn. Microbiol. Infect. Dis. 483 (2004) 153-160
16. Kerridge D., Koh T.Y., and Johnson A.M. The interaction of amphotericin B methyl ester with protoplasts of Candida albicans. J. Gen. Microbiol. 961 (1976) 117-123
17. Khot P.D., Suci P.A., Miller R.L., Nelson R.D., and Tyler B.J. A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes. Antimicrob. Agents Chemother. 5011 (2006) 3708-3716
18. Kretschmar M., Nichterlein T., Nebe C.T., Hof H., and Burger K.J. Fungicidal effect of tyrothricin on Candida albicans. Mycoses 391-2 (1996) 45-50
19. Latge J.P. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 122 (1999) 310-350
20. Lewis R.E., Wiederhold N.P., and Klepser M.E. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Antimicrob. Agents Chemother. 493 (2005) 945-951
21. Meletiadis J., Mouton J.W., Meis J.F., Bouman B.A., Donnelly J.P., and Verweij P.E. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 399 (2001) 3402-3408
22. Motulsky H. Intuitive Biostatistics (1995), Oxford University Press Inc., New York
23. NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts. NCCLS document M27-A (1997), NCCLS, Wayne, Pa
24. Patterson T.F. Fungal susceptibility testing: where are we now?. Transpl. Infect. Dis. 4 Suppl 3 (2002) 38-45
25. Perumal P., Mekala S., and Chaffin W.L. Antifungal drug resistance in Candida albicans biofilms: a role for cell density. Antimicrob. Agents Chemother. 51 7 (2007) 2454-2463
26. Pettit R.K., Weber C.A., Kean M.J., Hoffmann H., Pettit G.R., Tan R., et al. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob. Agents Chemother. 497 (2005) 2612-2617
27. Pfaller M.A., and Barry A.L. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol. 328 (1994) 1992-1996
28. Pfaller M.A. Antifungal susceptibility testing methods. Curr. Drug Targets. 68 (2005) 929-943
29. Pfaller M.A., Grant C., Morthland V., and Rhine-Chalberg J. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J. Clin. Microbiol. 322 (1994) 506-509
30. Ramage G., vande Walle K., Wickes B.L., and Lopez-Ribot J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 459 (2001) 2475-2479
31. Rex J.H., Pfaller M.A., Walsh T.J., Chaturvedi V., Espinel-Ingroff A., Ghannoum M.A., et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 144 (2001) 643-658
32. Roehm N.W., Rodgers G.H., Hatfield S.M., and Glasebrook A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods. 1422 (1991) 257-265
33. Ruhnke M. Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Curr. Drug Targets 74 (2006) 495-504
34. Seligy V.V., and Rancourt J. Antibiotic MIC/MBC analysis of Bacillus-based commercial insecticides: use of bioreduction and DNA-based assays. J. Ind. Microbiol. Biotechnol. 226 (1999) 565-574
35. Snydman D.R. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 1235 Suppl (2003) 500S-503S
36. Suci P.A., and Tyler B.J. A method for discrimination of subpopulations of Candida albicans biofilm cells that exhibit relative levels of phenotypic resistance to chlorhexidine. J. Microbiol. Meth. 533 (2003) 313-325
37. Tellier R., Krajden M., Grigoriew G.A., and Campbell I. Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob. Agents Chemother. 368 (1992) 1619-1625
38. To W.K., Fothergill A.W., and Rinaldi M.G. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 3310 (1995) 2660-2664
39. Tyler, B.J. and Khot, P.D., 2007. Kinetic metabolic assay for antifungal susceptibility testing. Free Patents Online (Pending US patent publication # 20070238146). Application # 11/706,632.
40. Van Vianen W., de Marie S., ten Kate M.T., Mathot R.A., and Bakker-Woudenberg I.A. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis. J. Antimicrob. Chemother. 574 (2006) 732-740
41. White T.C., Marr K.A., and Bowden R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 112 (1998) 382-407
42. Yamaguchi H., Uchida K., Nagino K., and Matsunaga T. Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole. J. Infect. Chemother. 84 (2002) 374-377